How anti-ageing peptides work, and what they do
Ageing isn’t one process. It’s a dozen of them running at different speeds in different parts of a cell, which is why the compounds sold as anti-ageing peptides so rarely do the same job as each other. A copper peptide and a vial of NAD+ have almost nothing in common beyond the shelf they sit on. This is a plain-English run through what peptides actually are, what happens once one is inside you, and where five of the better-studied compounds fit — including two that aren’t peptides at all.
What a peptide is, and why the body listens
A peptide is a short chain of amino acids. Longer chains, past about fifty links, get called proteins. That is genuinely the whole distinction, and it matters less than what the chain does.
Your body already runs on peptides. Insulin is one. So is oxytocin, so is the glucagon that lifts your blood sugar between meals, so are the growth-hormone-releasing signals your pituitary answers to. They work the way a key works, not the way a brick does — a peptide isn’t raw material the body melts down and builds with, it’s an instruction. It drifts until it meets a receptor shaped to accept it, binds, and the cell on the other side changes what it’s doing: switches on a gene, releases a hormone, starts laying down collagen.
Two practical consequences fall out of that. The first is specificity. Because the fit is physical, a peptide tends to do one or two things well rather than everything vaguely, which is why the useful ones have a mechanism you can describe in a sentence.
The second is that your digestive system is built to destroy them. Protein-digesting enzymes don’t distinguish between a steak and a signalling molecule, and a swallowed peptide is mostly taken apart into amino acids before it reaches your bloodstream. That single fact explains nearly every delivery format you’ll see: injectable, topical, nasal, under the tongue. It isn’t marketing theatre, it’s a workaround for an enzyme problem.
The damage these compounds are actually aimed at
Researchers describe ageing as a set of overlapping hallmarks rather than a single clock. Mitochondria produce less energy and leak more waste. Proteins misfold and the clean-up systems that should clear them slow down. DNA damage accumulates faster than repair crews can work through it. Some cells stop dividing but refuse to die, sitting in the tissue and emitting inflammatory signals — the senescent cells we covered in our piece on FOXO4-DRI and senescent cell research. Collagen and elastin turn over more slowly. Antioxidant reserves run down.
No compound addresses all of that. What the serious ones do is pick a mechanism and push on it, which means the sensible question about any of them is not “does it work” but “which of those problems is it even aimed at”. Three of the five below are peptides proper. One is a coenzyme. One is a small molecule that got filed under peptides because it shares a shelf with them. The grouping is a retail accident, not biology — but the five between them cover an unusually wide spread of the list above, which is why they end up discussed together.
GHK-Cu: the copper carrier that runs out
GHK is three amino acids long — glycine, histidine, lysine — and it has an unusual talent: it grabs a copper ion and holds it. Copper is essential for the enzymes that cross-link collagen and elastin, and it is also toxic loose in tissue, so the body moves it around clipped to carriers. GHK is one of those carriers, and the complex it forms is what gets abbreviated to GHK-Cu.
It occurs naturally in human plasma, and the concentration drops sharply with age — by well over half between your twenties and your sixties. That decline is the reason it became interesting: here is a signal your body used to send in quantity and now barely sends at all.
What it does on arrival is broad for something so small. It is studied for wound repair, for collagen and elastin production, for skin remodelling and hair follicle activity, and for damping inflammation. The strangest finding comes from gene-expression work by Loren Pickart’s group, which reported that GHK shifts the activity of thousands of human genes back toward a younger expression pattern — a 2018 review in the International Journal of Molecular Sciences walks through that gene data in detail. It is also among the few compounds here with decades of use behind it; it has been in skincare since the 1990s.
We stock it in 50mg and 100mg vials — the 100mg GHK-Cu vial is the one most people end up on, because the smaller size disappears quickly if it is being used on skin rather than injected.
AI-generated image
Glutathione: the antioxidant you make yourself
Glutathione is also a tripeptide — glutamate, cysteine and glycine — and it is the single most important antioxidant inside your cells. Not a vitamin you eat. One your body manufactures, continuously, and spends just as continuously.
It does three jobs. It neutralises reactive oxygen species directly, taking the hit so something structural doesn’t. It regenerates vitamins C and E after they have been used up, which means a decent glutathione level quietly multiplies the value of the antioxidants you do eat. And in the liver it binds to toxins during phase-two detoxification so they can be packaged up and excreted.
Production falls with age, with illness, and with sustained oxidative stress. A study in the American Journal of Clinical Nutrition found older adults were synthesising markedly less of it than younger controls, and that supplying the raw materials — cysteine and glycine — restored their levels within a fortnight. That is a useful result in both directions: the deficit is real, and it is a supply problem rather than a broken factory.
The cosmetic interest is separate and well known in Asia, where it is used for skin brightening: glutathione inhibits tyrosinase, the enzyme that makes melanin. Oral glutathione is poorly absorbed for the reasons described earlier, which is why the 600mg injectable glutathione vial exists at all.
SNAP-8: the one that works on the surface
SNAP-8 is the odd one out here, and deliberately so. It is an eight-amino-acid cosmetic peptide, properly called acetyl octapeptide-3, and it is used topically rather than injected.
Its mechanism is a clever piece of mimicry. Muscles contract when a nerve releases acetylcholine, and that release depends on a protein assembly called the SNARE complex, of which SNAP-25 is a component. SNAP-8 copies the end of the SNAP-25 sequence closely enough to compete for a place in that assembly. Less efficient assembly means a slightly weaker release signal, which means the constant micro-contractions that fold skin into expression lines ease off. It is the same target botulinum toxin acts on, approached from a completely different and far milder angle — a peptide sitting on the skin surface is not a neurotoxin injected into a muscle, and nobody should expect the same result.
Honest reading of the evidence: most published numbers come from manufacturer testing of finished serums rather than the peptide alone. A 2026 clinical study in the International Journal of Cosmetic Science on a serum built around acetyl hexapeptide-8 — SNAP-8’s shorter and better-studied relative — reported static wrinkle scores improving between 35% and 69% over twelve weeks, with dynamic wrinkles shifting far less. The serum contained several actives, so the peptide can’t claim all of that. We keep SNAP-8 in 10mg vials for people formulating their own.
NAD+: the currency the repair crew spends
NAD+ is not a peptide. It is a coenzyme, present in every cell you have, and it sits at the centre of two unrelated stories.
The first is energy. NAD+ carries electrons through the reactions that turn food into ATP. Without enough of it, mitochondria simply produce less.
The second is maintenance, and it is the reason the longevity field cares. Sirtuins and PARPs — the enzyme families responsible for DNA repair and a good deal of cellular housekeeping — consume NAD+ as a substrate. They don’t borrow it, they spend it. So the same molecule funds your energy production and your repair crew, and when the pool shrinks, those two compete. Levels fall substantially with age, a decline a review in Nature Reviews Molecular Cell Biology traces through both reduced synthesis and increased consumption by the very repair processes that need it.
Oral precursors like NR and NMN are the popular route, and they work by being converted after absorption. Injectable NAD+ sidesteps that conversion entirely, which is the argument for the 1000mg NAD+ vial over a capsule. What nobody can tell you yet is how much of the supplied molecule reaches the compartments where it is actually spent — that remains the open question in the whole NAD+ field, and anyone who tells you it is settled is selling something.
5-Amino-1MQ: blocking the enzyme that eats the supply
This one is also not a peptide. It is a conventional small molecule, and it belongs in this article because of what it is aimed at.
There is an enzyme called NNMT, abundant in fat tissue, which quietly consumes two things your cells need: nicotinamide, a building block of NAD+, and SAM, the body’s main methyl donor. In obesity, NNMT activity rises. 5-Amino-1MQ inhibits it, and the reasoning is that blocking the drain leaves more of both available — more raw material for NAD+ in particular.
The animal data is genuinely interesting. In research published in Biochemical Pharmacology, diet-induced obese mice given the compound for eleven days lost about 5% of their body weight while untreated controls gained a little; fat pad mass fell roughly 35% and individual fat cells shrank by over 30%. The finding that gets quoted most is that food intake did not change — the effect was metabolic, not appetite suppression.
The honest caveats are equally clear. That was nine mice per group over eleven days, at a dose three times daily. There are no completed human trials. It is banned in sport under the WADA S0 category, which covers substances with no approval for human therapeutic use. Our 50mg 5-Amino-1MQ vial is sold on the same research-use basis as everything else here, and the gap between a mouse study and a person is wider than the marketing around this compound usually admits.
Where anti-ageing peptides overlap, and where they don’t
Lay the five side by side and the redundancy is smaller than it looks. GHK-Cu works on the extracellular matrix — collagen, elastin, repair signalling in tissue. Glutathione works on oxidative load and the liver. SNAP-8 works on muscle signalling, at the surface, and never enters the conversation the other four are having. NAD+ and 5-Amino-1MQ are the only genuine pair, and even they approach from opposite ends: one supplies the molecule, the other stops an enzyme consuming its precursor.
That is the sensible way to think about combining anything in this category. Two compounds aimed at the same mechanism are a duplicate. Two aimed at different mechanisms are not a stack in any mystical sense — they are just two separate experiments you are running at once, which is also exactly why starting them in the same week is a poor idea. You learn nothing about either.
What the evidence supports, and what it doesn’t
Three honest tiers. GHK-Cu and glutathione have the longest histories and the most human data behind them, though much of the glutathione literature concerns correcting a deficiency rather than enhancing a normal level. SNAP-8 has real cosmetic testing behind it but the numbers belong to finished formulations. NAD+ and 5-Amino-1MQ are the most interesting and the least settled — strong mechanisms, convincing animal work, open human questions.
None of this is approved therapy in Australia, and none of it should be read as a dosing recommendation. These are research compounds, sold and discussed as research compounds. If you are going to work with them, the boring things matter more than the exciting ones: reconstitute correctly, keep them cold, and keep them dark — our guide to storing peptides properly covers how quickly a mishandled vial stops being what you paid for. And if you are at the age where this article found you, a blood panel first beats guesswork, the same argument we made about supplements worth considering after 40.
The field is moving quickly, and the most useful habit is the dullest one: change one thing at a time, give it eight to twelve weeks, and write down what actually happened.
This article is general information about research compounds, not medical advice, and nothing here is a treatment for any condition. None of the compounds discussed are approved therapies in Australia. Speak to your doctor or pharmacist before starting anything new, particularly if you take prescription medication.